115 related articles for article (PubMed ID: 9829628)
1. Induction of Fas ligand and Fas antigen mRNA expressions in interferon-gamma transgenic mouse liver.
Okamoto T; Yamakawa T; Yamamura K; Hino O
Jpn J Pharmacol; 1998 Oct; 78(2):233-5. PubMed ID: 9829628
[TBL] [Abstract][Full Text] [Related]
2. The mouse interferon-gamma transgene chronic hepatitis model (Review).
Okamoto T; Yamamura K; Hino O
Int J Mol Med; 1999 May; 3(5):517-20. PubMed ID: 10202184
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha gene expression in the liver of the IFN-gamma transgenic mouse with chronic active hepatitis.
Okamoto T; Furuya M; Yamakawa T; Yamamura K; Hino O
Biochem Biophys Res Commun; 1996 Sep; 226(3):762-8. PubMed ID: 8831687
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells.
Roth E; Pircher H
J Immunol; 2004 Feb; 172(3):1588-94. PubMed ID: 14734739
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol.
Li M; Liu GT
World J Gastroenterol; 2004 Jun; 10(12):1775-9. PubMed ID: 15188504
[TBL] [Abstract][Full Text] [Related]
6. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.
Chen D; McKallip RJ; Zeytun A; Do Y; Lombard C; Robertson JL; Mak TW; Nagarkatti PS; Nagarkatti M
J Immunol; 2001 May; 166(10):5889-97. PubMed ID: 11342603
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Fas ligand to T cell-mediated hepatic injury in mice.
Seino K; Kayagaki N; Takeda K; Fukao K; Okumura K; Yagita H
Gastroenterology; 1997 Oct; 113(4):1315-22. PubMed ID: 9322527
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis.
Tagawa Y; Kakuta S; Iwakura Y
Eur J Immunol; 1998 Dec; 28(12):4105-13. PubMed ID: 9862346
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis in interferon-gamma transgenic mice is associated with elevated CPP32-like activity and interleukin-1beta-converting enzyme activity suppression.
Okamoto T; Nakano Y; Yamakawa T; Hara K; Yamamura KI; Hino O
Jpn J Pharmacol; 1999 Mar; 79(3):289-94. PubMed ID: 10230856
[TBL] [Abstract][Full Text] [Related]
10. Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithelial apoptosis.
Wigginton JM; Park JW; Gruys ME; Young HA; Jorcyk CL; Back TC; Brunda MJ; Strieter RM; Ward J; Green JE; Wiltrout RH
J Immunol; 2001 Jan; 166(2):1156-68. PubMed ID: 11145697
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation.
Müschen M; Warskulat U; Peters-Regehr T; Bode JG; Kubitz R; Häussinger D
Gastroenterology; 1999 Mar; 116(3):666-77. PubMed ID: 10029626
[TBL] [Abstract][Full Text] [Related]
12. End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas.
Robinson RT; Wang J; Cripps JG; Milks MW; English KA; Pearson TA; Gorham JD
J Immunol; 2009 Mar; 182(5):3278-84. PubMed ID: 19234226
[TBL] [Abstract][Full Text] [Related]
13. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.
Inui T; Nakagawa R; Ohkura S; Habu Y; Koike Y; Motoki K; Kuranaga N; Fukasawa M; Shinomiya N; Seki S
J Immunol; 2002 Dec; 169(11):6127-32. PubMed ID: 12444115
[TBL] [Abstract][Full Text] [Related]
14. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
15. IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice.
Faggioni R; Cattley RC; Guo J; Flores S; Brown H; Qi M; Yin S; Hill D; Scully S; Chen C; Brankow D; Lewis J; Baikalov C; Yamane H; Meng T; Martin F; Hu S; Boone T; Senaldi G
J Immunol; 2001 Nov; 167(10):5913-20. PubMed ID: 11698468
[TBL] [Abstract][Full Text] [Related]
16. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes.
Tagawa Y; Sekikawa K; Iwakura Y
J Immunol; 1997 Aug; 159(3):1418-28. PubMed ID: 9233639
[TBL] [Abstract][Full Text] [Related]
17. Expression of the inducible form of the nitric oxide synthase gene in the livers of mice with chronic hepatitis.
Okamoto T; Yamamura K; Hino O
Int J Mol Med; 2000 Sep; 6(3):315-7. PubMed ID: 10934296
[TBL] [Abstract][Full Text] [Related]
18. Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.
Lian F; Wang Y; Xiao Y; Wu X; Xu H; Liang L; Yang X
Mol Med Rep; 2015 Oct; 12(4):5821-7. PubMed ID: 26238153
[TBL] [Abstract][Full Text] [Related]
19. Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen.
Ohta A; Sekimoto M; Sato M; Koda T; Nishimura S; Iwakura Y; Sekikawa K; Nishimura T
J Immunol; 2000 Jul; 165(2):956-61. PubMed ID: 10878371
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice.
Lamy T; Bauer FA; Liu JH; Li YX; Pillemer E; Shahidi H; Gregory SA; Zambello R; Marcolongo R; Semenzato G; Loughran TP
Br J Haematol; 2000 Mar; 108(4):717-23. PubMed ID: 10792274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
